Skip Navigation

Research

Global Projects

Search

Statins as Adjunctive Therapy for Tuberculosis (StAT-TB)


Summary

The goal of this study is to investigate the potential utility of pravastatin as an adjunctive, host-directed therapy for drug-susceptible pulmonary TB in a two-stage randomized control trial. Stage 1 is a 30-day PK/tolerability study and Stage 2 is a 12-month efficacy study. The primary outcomes will be safety/toxicity, median time to sputum culture conversion, and lung function outcomes.

Dates

  • Start Date: 
    02/26/2020
  • End Date: 
    02/24/2023

Project Type

Locations

Researchers